Abbvie

HUMIRA

  1. Home
  2.  / 
  3. J Code
  4.  / HUMIRA – J0135

Manufacturer:

Abbvie

Name:

HUMIRA

HCPCS Code Descriptor:

Injection, adalimumab, 20 mg

Category:

J Code

HCPCS:

J0135

NDC(s):

00074-0067-02, 00074-0124-02, 00074-0124-03, 00074-0124-04, 00074-0243-02, 00074-0554-02, 00074-0616-02, 00074-0817-02, 00074-1539-03, 00074-2540-03, 00074-3799-02, 00074-4339-02, 00074-4339-06, 00074-4339-07

Primary Type:

Immunology:Anti-TNF

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

HUMIRA is an Immunology:Anti-TNF drug manufactured by Abbvie and administered via the Subcutaneous route of administration. The J Code: J0135 is aligned to the drug HUMIRA.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/05

HCPCS Effective Date:

1/1/05

HCPCS Short Description:

Adalimumab injection

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.abbvie.com/patients/patient-assistance/program-qualification/humira-program-selection.html